Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 2 of 2 (100%) have an AI response strategy ready • 4 patents granted in the last 365 days
Oryzon Genomics S A is currently managing a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio contains 2 pending office actions, indicating an active phase of prosecution for multiple applications. This volume suggests that the company is simultaneously advancing several different aspects of its genomic or pharmaceutical research through the patent office.
The prosecution is distributed across 2 distinct examiners and 2 distinct art units. This distribution means that the company's legal strategy must account for different examination styles and technical standards across these 2 distinct art units. For the practitioner, this requires a more complex approach than a single-examiner portfolio, as each of the 2 pending office actions may be subject to different technical interpretations within the Biotechnology & Pharmaceuticals sector.
VISHNYAKOVA, ELENA VLADIMIROVNA is the busiest examiner for Oryzon Genomics S A, currently handling 1 busiest examiner pending office action. This 1 action is one of the 2 pending office actions currently active for the company. While VISHNYAKOVA, ELENA VLADIMIROVNA is the busiest, the workload is split between the 2 distinct examiners, requiring the company to manage its responses to both individuals to ensure the overall progress of the portfolio.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VISHNYAKOVA, ELENA VLADIMIROVNA | 1 | 65.8% | +51.3% |
| CHANDRAKUMAR, NIZAL S | 1 | 72.7% | +18.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18455098 | VAFIDEMSTAT FOR USE IN TREATING AUTISM SPECTRUM DISORDERS | VISHNYAKOVA, ELENA VLADIMIROVNA | 40d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18455098 | VAFIDEMSTAT FOR USE IN TREATING AUTISM SPECTRUM DISORDERS | VISHNYAKOVA, ELENA VLADIMIROVNA | 40d |
| 18451897 | METHODS OF TREATING BEHAVIOR ALTERATIONS | CHANDRAKUMAR, NIZAL S | 70d |
| Art Unit | Apps |
|---|---|
| 1691 | 1 |
| 1625 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18455098 | VAFIDEMSTAT FOR USE IN TREATING AUTISM SPECTRUM DISORDERS | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | §102§103§112 | Non-Final OA | 40d | AI Ready | Aug 24, 2023 |
| 18451897 | METHODS OF TREATING BEHAVIOR ALTERATIONS | CHANDRAKUMAR, NIZAL S | 1625 | §112 | Final Rejection | 70d | AI Ready | Aug 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial